Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h

Google maps

Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :

Belarus pilots new financial model to strengthen ambulatory tuberculosis care

A WHO/Green Light Committee mission visited Belarus on 1–5 December 2014, to monitor the treatment of multidrug-resistant tuberculosis (MDR-TB) and review a pilot financing project. International experts from Latvia (the head of a WHO collaborating centre and the head of the MDR-TB department at a TB hospital) visited the republican TB prison in Orsha, Vitebsk region and TB...


Source Source: WHO/Europe

Report from the Regional meeting access to treatment in Central and South East Europe in Skopje

The first Regional meeting on access to HIV treatment in Central and South East Europe took place in Skopje, Macedonia from 24 to 27 October 2014. You can access the report here . Call for Action! Call for Action directed at governments of the NeLP countries, pharmaceutical companies, and HIV/AIDS activists


Source Source: NeLP

Short course in latent TB matches standard treatment

Also, treatment for tuberculosis pericarditis advances Short courses of rifamycin-containing treatment regimens prevented active tuberculosis (TB) as well as standard monotherapy did, researchers reported. In a Bayesian network meta-analysis, some of the rifamycin-containing regimens also were less likely to cause liver damage than standard therapy with isoniazid...


Source Source: MedPage Today

Latvia to host ground-breaking conference on TB in Europe

16 December 2014 - Geneva, Switzerland - Latvia holding the Presidency of the European Union in the first half of 2015 will host the first European ministerial conference on tuberculosis and drug resistance on the 31st of March in Riga. Working together, the Global Fund to Fight AIDS, Tuberculosis and Malaria, WHO’s European Region, ECDC, the EC, TB Europe Coalition,...


Anti-diabetic drug springs new hope for tuberculosis patients

Drug for treating diabetes can double up as adjunct treatment for tuberculosis SINGAPORE, Dec 17, 2014 - A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing drug resistance. This discovery was made by...


Source Source: A*STAR